Common symptoms include reduced appetite, mild nausea, early satiety after small meals, and minor changes in bowel habits such as constipation or loose stools
Cutaneous Side Effects GLP-1 receptor agonists are being prescribed more than ever, both for diabetes and weight management, and dermatologists are increasingly seeing patients who are taking these medications and in some cases, prescribing them themselves, said Marisa Fat, BS, a medical student at the Anne Burnett Marion School of Medicine at Texas Christian University
Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach
While Retatrutide is still being studied and not-yet FDA approved, clinical trials have sparked interest, with some health experts calling it a potential next-generation weight loss treatment
For those who experience nocturnal heartburn, taking an antacid in the evening (well separated from the morning Rybelsus dose) is generally safe
As appetite control and metabolic health become mainstream concerns, companies must act decisively to reformulate offerings, validate health claims, and align with evolving dietary behaviours focusing on nutrition-first approach to tackle these shifts